Product Uses
Cerenia tablets are indicated for the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.
Product Contains
maropitant citrate
Dosage and Administration
For the prevention of acute vomiting, Cerenia tablets should be administered by mouth at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days.
For the prevention of vomiting due to motion sickness, Cerenia tablets should be administered by mouth at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days. The medication should be given 2 hours prior to travel for optimal effectiveness. Dogs should be fasted for 1 hour prior to administration of Cerenia tablets.
Warnings, Side Effects and Drug Interactions
Cerenia Tablets are recommended for use in dogs over 16 weeks age only. The safe use of Cerenia Tablets has not been evaluated in dogs used for breeding, pregnant or lactating dogs, animals with gastrointestinal obstruction, or that have ingested toxins. Cerenia should be used with caution in dogs with liver disease and in animals being treated concomitantly with other medications that are highly protein bound (e.g. NSAIDs, cardiac, anticonvulsant and behavioral medications) or those which may affect enzyme metabolizing systems of the body.
Cerenia Tablets have been used safely in dogs receiving other commonly used veterinary products such as fluid and electrolyte replacement solutions, antimicrobial agents, vaccines, antacids, and antiparasitic agents.
The following adverse reactions have been seen on rare occasions in animals being treated with Cerenia for acute vomiting: diarrhea, blood in the feces, anorexia, ear disease, shock, blood in the urine, skin abrasions, death. The following have been observed in animals treated with Cerenia for motion sickness: salivation, vomiting, trembling, sedation/lethargy, retching, flatulence, loss of appetite, weight loss, soft stools or mucus in the feces. Overdosing of the medication increases the likelihood of these reactions, in addition to a decreased heart rate.
Not for use in humans. Keep out of reach of children. In case of accidental ingestion, seek medical advice. Topical exposure may elicit localized allergic skin reactions in some individuals. Repeated or prolonged exposure may lead to skin sensitization. Wash hands with soap and water after administering drug. Cerenia is also an ocular irritant. In case of accidental eye exposure, flush with water for 15 minutes and seek medical attention
Storage
Cerenia Tablets should be stored at controlled room temperature 20<°-25<°C (68<°-77<°F) with excursions between 15<°-30<°C (59<°-86<°F).
Manufacturer
Pfizer Animal Health
Registration Status
NADA #141-262, Approved by FDA
Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.
Cerenia
